Filtros de búsqueda

Lista de obras de Séverine Vermeire

(Auto)antibodies in inflammatory bowel diseases

artículo científico publicado en 2008

1002 - Predictive Serological Markers of Response to Ustekinumab in Patients with Refractory Crohn's Provide Novel Insights in the Mechanism of Action

artículo científico publicado en 2018

1006 – Histologic Remission and Mucosal Healing in a Randomized, Placebo-Controlled, Phase 2 Study of Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis

scholarly article

1007 – Abx464 is Safe and Efficacious in Proof of Concept Study in Ulcerative Colitis Patients

scholarly article

2020 international consensus on ANCA testing beyond systemic vasculitis

artículo científico publicado en 2020

333 – Trem1, the First Anti-TNF Specific Biomarker Guiding Therapeutic Decision in Inflammatory Bowel Disease

scholarly article

5-Aminosalicylate is Not Protective From Neoplasia in Ulcerative Colitis

scholarly article by Talat Bessissow et al published June 2013 in The American Journal of Gastroenterology

536 – Predicting Vedolizumab Induced Endoscopic Remission in Patients with Inflammatory Bowel Disease Via a Specific Four-Gene Colonic Signature

scholarly article

764 Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study ⬇️

scholarly article

764 Results of Andante, a Randomized Clinical Study With an Anti-IL6 Antibody (PF-04236921) in Subjects With Crohn's Disease Who Are Anti-TNF Inadequate Responders

772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II ⬇️

scholarly article

835 – Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results from the Gemini Lts Study

scholarly article

879 – Switching from Infliximab Originator to a Biosimilar Does Not Affect Pharmacokinetics, Immunogenicity and Efficacy in Pediatric Patients with Inflammatory Bowel Disease

scholarly article

95 – Serum Proteomic Profiling in Ulcerative Colitis Patients Undergoing Ileoanal Pouch Surgery Reveals Predictive and Diagnostic Markers for Pouchitis

scholarly article

A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease

scientific article published on 02 August 2016

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease

artículo científico publicado en 2015

A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis

artículo científico publicado en 2020

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease

artículo científico publicado en 2016

A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study ⬇️

scholarly article

A Simplified Geboes Score for Ulcerative Colitis.

artículo científico publicado en 2017

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

artículo científico publicado en 2013

A microbial signature for Crohn's disease

artículo científico publicado en 2017

A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis

artículo científico publicado en 2014

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

artículo científico publicado en 2016

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

artículo científico publicado en 2013

A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease

artículo científico publicado en 2014

A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases

artículo científico publicado en 2017

A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis

artículo científico publicado en 2022

A20 controls intestinal homeostasis through cell-specific activities

artículo científico publicado en 2014

ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior.

artículo científico publicado en 2013

AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.

artículo científico publicado en 2016

Accurate determination of copy number variations (CNVs): application to the alpha- and beta-defensin CNVs.

artículo científico publicado en 2009

Adalimumab in Crohn's disease

artículo científico publicado en 2007

Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease

artículo científico publicado en 2019

Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study

artículo científico publicado en 2015

Altered Colonic Metabolite Profile in Active Versus Quiescent Ulcerative Colitis

artículo científico publicado en 2011

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

artículo científico publicado en 2007

An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases

artículo científico publicado en 2015

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

article

Analysis of Genes Associated with Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's disease.

artículo científico publicado en 2018

Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.

artículo científico publicado en 2001

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2017

Anti-MAdCAM antibody for induction of remission in ulcerative colitis

artículo científico publicado en 2015

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

artículo científico publicado en 2019

Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases

artículo científico publicado en 2015

Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.

artículo científico publicado en 2008

Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time

artículo científico publicado en 2017

Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases

Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial

artículo científico publicado en 2015

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

article

Antibody responses in Crohn’s disease

article

Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls

artículo científico publicado en 2013

Assessing disease activity in ulcerative colitis using artificial intelligence: can "equally good" be seen as "better"?

artículo científico publicado en 2020

Assessment of the microbiota in microdissected tissues of Crohn's disease patients

artículo científico publicado en 2011

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.

artículo científico publicado en 2004

Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies

scientific article published on 25 April 2013

Association of Faecalibacterium Prausnitzii and Disease Activity in Ulcerative Colitis

scholarly article

Association of Organic Cation Transporter Risk Haplotype With Perianal Penetrating Crohn’s Disease but Not With Susceptibility to IBD

article

Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease

artículo científico publicado en 2012

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

artículo científico publicado en 2003

Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial

artículo científico

Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease: a review on behalf of ECCO and EBMT.

artículo científico publicado en 2018

Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density

artículo científico publicado en 2020

Autophagy and Crohn’s Disease

Autophagy: a new target or an old strategy for the treatment of Crohn's disease?

artículo científico

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease

artículo científico publicado en 2016

Betting on quality indicators to improve inflammatory bowel disease surveillance outcome: All-in or one to pick?

scientific article published on 27 November 2019

Big data in IBD: big progress for clinical practice

artículo científico publicado en 2020

Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium

artículo científico publicado en 2020

Biological therapies for inflammatory bowel diseases

artículo científico publicado en 2009

Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease

artículo científico publicado en 2016

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target

artículo científico publicado en 2014

Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis

scientific article published on 01 September 2019

Butyricicoccus pullicaecorum in inflammatory bowel disease

artículo científico publicado en 2012

C-reactive protein as a marker for inflammatory bowel disease

artículo científico publicado en 2004

CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure

scientific article published on 17 May 2002

CC chemokine receptor 5 (CCR-5) and serological markers ASCA and pANCA in inflammatory bowel disease (IBD)

CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.

artículo científico publicado en 2006

Calprotectin as a Biomarker for Remission in UC Patients Under IFX Therapy

artículo científico publicado en 2011

Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study

artículo científico publicado en 2011

Candida albicans colonization and ASCA in familial Crohn's disease

artículo científico publicado en 2009

Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study

artículo científico publicado en 2017

Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab

artículo científico publicado en 2010

Certolizumab pegol in the treatment of Crohn's disease

artículo científico

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study

artículo científico publicado en 2015

Chemokine receptor CCR5 Δ32 gene polymorphism in Crohn's disease and ulcerative colitis

article

Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial

artículo científico publicado en 2017

Classification of inflammatory bowel disease: the old and the new.

artículo científico

Clinical and genetic factors associated with sacroiliitis in Crohn's disease

artículo científico publicado en 2007

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

artículo científico publicado en 2015

Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

artículo científico publicado en 2017

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.

artículo científico publicado en 2016

Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades

artículo científico publicado en 2019

Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease

artículo científico publicado en 2008

Clustering of increased small intestinal permeability in families with Crohn's disease.

artículo científico publicado en 1997

Coamplification of eukaryotic DNA with 16S rRNA gene-based PCR primers: possible consequences for population fingerprinting of complex microbial communities

artículo científico publicado en 2008

Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease

artículo científico publicado en 2012

Common variants at five new loci associated with early-onset inflammatory bowel disease

artículo científico publicado en 2009

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

artículo científico publicado en 2008

Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy

artículo científico publicado en 2016

Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development

scientific article published on 26 October 2018

Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis

artículo científico publicado en 2020

Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.

artículo científico publicado en 2016

Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort

artículo científico publicado en 2009

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.

artículo científico publicado en 2013

Contemporary methods for the diagnosis and treatment of microscopic colitis

artículo científico

Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases

artículo científico publicado en 2007

Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis

scholarly article by Bart Lemmens et al published May 2013 in Inflammatory Bowel Diseases

Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity

artículo científico publicado en 2010

Corrigendum to “Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis” [J Crohn's and Colitis 4 (2010) 683–6. Epub 2010 Jul 14]

scholarly article published in Journal of Crohn's and Colitis

Corrigendum: Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome

scientific article published on 01 October 2019

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

artículo científico publicado en 2009

Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation

artículo científico publicado en 2006

Crohn's Disease

Crohn's Disease Patients With Persistently Elevated CRP Plasma Concentration Have Higher Rates of Remission With Certolizumab Pegol 400 mg Every 2 Weeks vs. Every 4 Weeks

artículo científico publicado en 2011

Crohn's Disease: Infliximab Trough Levels and CRP During Infliximab-Immunomodulator Combination Treatment Are Associated With Clinical Outcome After Immunomodulator Withdrawal

artículo científico publicado en 2011

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort

artículo científico publicado en 2005

Crohnʼs Disease and Month of Birth

artículo científico publicado en 2005

Current status of genetics research in inflammatory bowel disease.

artículo científico publicado en 2005

Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature ⬇️

artículo científico publicado el 1 de octubre de 2010

Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease

artículo científico publicado en 2019

Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.

artículo científico publicado en 2008

DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.

artículo científico publicado en 2006

Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.

artículo científico publicado en 2012

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

artículo científico publicado en 2013

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis

artículo científico publicado en 2004

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

artículo científico publicado en 2016

Defining Endoscopic Remission in Ileocolonic Crohn's Disease: Let's Start from Scratch

artículo científico publicado en 2018

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

artículo científico publicado en 2002

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

artículo científico publicado en 2013

Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction

artículo científico publicado en 2007

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

artículo científico publicado en 2012

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.

artículo científico publicado en 2017

Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins

scientific article published on 08 November 2019

Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy

artículo científico publicado en 2020

Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease

artículo científico publicado en 2017

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization

artículo científico publicado en 2014

Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes

artículo científico publicado en 2007

Diagnostic Accuracy of Ten Second-Generation (Human) Tissue Transglutaminase Antibody Assays in Celiac Disease

artículo científico publicado en 2004

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease

artículo científico publicado en 2001

Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome

scientific article published on 01 March 2019

Differences between adults and children: genetics and beyond

artículo científico publicado en 2014

Differential diagnosis of inflammatory bowel disease: imitations and complications

artículo científico publicado en 2018

Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.

artículo científico publicado en 2006

Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?

artículo científico publicado en 2020

Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.

artículo científico publicado en 2006

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

artículo científico publicado en 2015

Drug Development for Inflammatory Bowel Disease: Interaction Among Academia, Industry and Regulatory Authorities

artículo científico publicado en 2016

Drug safety evaluation of certolizumab pegol

artículo científico

Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach

artículo científico publicado en 2021

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

artículo científico publicado en 2011

Early Trough Levels and Antibodies Predict Safety and Success of Restarting Infliximab After Long Drug Holiday

artículo científico publicado en 2011

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

artículo científico publicado en 2015

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

artículo científico publicado en 2008

Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment: Table 1

article

Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy

artículo científico publicado en 2014

Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' reply

artículo científico publicado en 2019

Effect of Oligofructose Enriched Inulin (OF-IN) on Bacterial Composition and Disease Activity of Crohn's Disease Patients: Results From a Double-Blind Randomized Controlled Trial

artículo científico publicado en 2011

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study

artículo científico publicado en 2017

Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial: Table 1

article

Effect of phenotype on health care costs in Crohn’s disease: A European study using the Montreal classification

article

Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.

artículo científico publicado en 2016

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

artículo científico publicado en 2007

Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease

Effects of Increased Vedolizumab Dosing Frequency on Disease Activity in Ulcerative Colitis and Crohn’s Disease ⬇️

scholarly article

Effects of Infliximab Therapy on Transmural Lesions Assessed by MRI Enteroclysis in Patients With Ileal Crohn's Disease: The ACTIF Study

artículo científico publicado en 2011

Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis

artículo científico publicado en 2011

Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease

artículo científico publicado en 2013

Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care

artículo científico publicado en 2017

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis

scientific article published on 23 November 2018

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 09 November 2019

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 28 August 2019

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

artículo científico publicado en 2016

Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series

artículo científico publicado en 2010

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists.

artículo científico publicado en 2017

Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease

scientific article published on 01 June 2019

Electronic Clinical Challenges and Images in GI

artículo científico publicado en 2008

Emerging biological treatments in inflammatory bowel diseases

artículo científico publicado en 2006

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

artículo científico publicado en 2012

Endoscopic therapy of strictures in Crohn's disease

artículo científico publicado en 2007

Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease

scientific article published on 04 July 2019

Endoscopy in Inflammatory Bowel Diseases

Environmental Factors in Familial Crohnʼs Disease in Belgium

article

Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?

artículo científico publicado en 2017

Erratum to “Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study” [J Crohns Colitis (2011) 5, 430-442]

scholarly article published in Journal of Crohn's and Colitis

Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

artículo científico publicado en 2016

Erratum: Corrigendum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scholarly article published in Nature Genetics

Erratum: Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Respo

article

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

artículo científico publicado en 2014

Etrolizumab for induction of remission in ulcerative colitis

artículo científico publicado en 2015

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program

artículo científico publicado en 2020

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

artículo científico publicado en 2006

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

article

European evidenced-based consensus on reproduction in inflammatory bowel disease

artículo científico publicado en 2010

Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center

artículo científico publicado en 2020

Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center

scientific article published on 01 March 2020

Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations

scientific article published on 02 March 2020

Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohnʼs disease

artículo científico publicado en 2006

Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease

artículo científico publicado en 2015

Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in Caucasians.

artículo científico publicado en 2010

Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases

scientific article published on 25 April 2018

Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease

artículo científico publicado en 2017

Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies

scientific article published on 25 October 2019

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

artículo científico publicado en 2017

Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases

scientific article published on 22 August 2019

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

artículo científico publicado en 2012

FISH analysis of Lactobacillus biofilms in the gastrointestinal tract of different hosts

article

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.

artículo científico publicado en 2014

Familial Crohn??s Disease in Belgium

article

Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohnʼs disease

article

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

artículo científico publicado en 2011

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

artículo científico publicado en 2012

Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients

artículo científico publicado en 2015

Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13

scientific article published on 11 July 2019

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells

scientific article published on 21 June 2020

Fine-mapping inflammatory bowel disease loci to single-variant resolution

artículo científico publicado en 2017

Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies

artículo científico publicado en 2006

Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts.

artículo científico publicado en 2007

Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease

scientific article published on 01 July 2019

Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays

artículo científico publicado en 2016

Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays

artículo científico publicado en 2015

Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.

artículo científico publicado en 2016

Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative Colitis

artículo científico publicado en 2020

Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?

article

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.

artículo científico publicado en 2017

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease

artículo científico publicado en 2013

Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress.

artículo científico publicado en 2013

Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review

artículo científico publicado en 2011

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

artículo científico publicado en 2012

Genetic risk profiling and prediction of disease course in Crohn's disease patients

artículo científico publicado en 2009

Genetic susceptibility and genotype-phenotype association in 588 Danish children with inflammatory bowel disease

artículo científico publicado en 2014

Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome

artículo científico publicado en 2013

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients

article

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

artículo científico publicado en 2009

Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease.

artículo científico publicado en 2010

Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis

artículo científico publicado en 2009

Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia

artículo científico publicado en 2013

Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis

artículo científico publicado en 2004

Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease

artículo científico publicado en 2015

Genome-wide association analysis in primary sclerosing cholangitis

artículo científico publicado en 2009

Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4

scientific journal article

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

scientific journal article

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

artículo científico publicado en 2008

Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).

artículo científico publicado en 2010

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

artículo científico publicado en 2016

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

artículo científico publicado en 2010

Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease.

artículo científico publicado en 2010

GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD

artículo científico publicado en 2019

Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information

scientific article published on 18 December 2018

Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples

artículo científico publicado en 2016

Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.

artículo científico publicado en 2018

High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?

artículo científico publicado en 2015

High Levels of Thrombin Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor Are a Risk Factor for Thromboembolism: A Case-Control Study in IBD Patients

artículo científico publicado en 2011

High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake.

artículo científico publicado en 2010

Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

scientific article published on 01 November 2018

Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

artículo científico publicado en 2016

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

artículo científico publicado en 2012

How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases

artículo científico publicado en 2016

How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?

artículo científico publicado en 2019

Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology

artículo científico publicado en 2017

Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent

artículo científico publicado en 2005

IBD and health-related quality of life -- discovering the true impact

artículo científico publicado en 2014

IBD in 2012: Pathogenesis and management of IBD--thinking outside the box.

artículo científico

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

artículo científico publicado en 2018

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

artículo científico

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

article

Identification of a novel autoantigen in inflammatory bowel disease by protein microarray

scientific article published on 25 October 2010

Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile.

artículo científico publicado en 2016

Identifying predictors of low adherence in patients with inflammatory bowel disease

artículo científico publicado en 2016

IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.

artículo científico publicado en 2009

Immune reactivity to -tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders

artículo científico publicado en 2010

Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor.

artículo científico publicado en 2017

Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients

scientific article published on 16 January 2019

Immunogenicity of biologics in inflammatory bowel disease

artículo científico publicado en 2018

Immunogenicity of infliximab: how to handle the problem?

artículo científico publicado en 2007

Immunogenicity to infliximab is associated with HLA-DRB1.

artículo científico publicado en 2015

Immunosuppression in inflammatory bowel disease: traditional, biological or both?

artículo científico publicado en 2009

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study

artículo científico publicado en 2017

Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial

scientific article published on 15 January 2019

Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

scientific article published on 24 March 2019

Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.

artículo científico publicado en 2010

Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*

artículo científico publicado en 2011

Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay

artículo científico publicado en 2011

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

artículo científico publicado en 2006

Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment

artículo científico publicado en 2016

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

artículo científico publicado en 2018

Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease

article published in 2009

Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials

artículo científico publicado en 2019

Inflammatory bowel disease and Parkinson's disease: common pathophysiological links

scientific article published on 16 October 2020

Inflammatory bowel disease and colitis: new concepts from the bench and the clinic

scientific article published on January 2011

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis

artículo científico publicado en 2015

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease

scientific article published on 28 April 2020

Infliximab Induces Regulatory Macrophages in Responders but Not in Non-Responders

artículo científico publicado en 2011

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

article

Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study

artículo científico publicado en 2010

Infliximab for Severe IV Steroid-Refractory Ulcerative Colitis: Can Infliximab Trough Levels Guide Our Management?

artículo científico publicado en 2011

Infliximab therapy for patients with inflammatory bowel disease: 10 years on.

artículo científico publicado en 2009

Infliximab: the evidence for its place in therapy in ulcerative colitis.

artículo científico publicado en 2008

Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients

scientific article published on 01 March 2020

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

artículo científico publicado en 2009

Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing

scientific article published on 15 August 2018

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

artículo científico publicado en 2015

Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

artículo científico publicado en 2017

Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expression

artículo científico publicado en 2022

Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis

artículo científico publicado en 2014

Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.

artículo científico publicado en 2004

Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease

artículo científico publicado en 2002

Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab

artículo científico publicado en 2013

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases

artículo científico publicado en 2016

Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrence

artículo científico publicado en 2012

Intestinal expression of SHIP in inflammatory bowel diseases

artículo científico publicado en 2011

Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue seems downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon

scientific article published on 11 September 2020

Intravenous iron therapy restores functional iron deficiency induced by infliximab

Investing in workability of patients with inflammatory bowel disease: results of a pilot project Activ84worK (Activate for work)

artículo científico publicado en 2019

JAK Inhibitors: Back to Small Molecules for the Treatment of IBD

scientific article published on 01 August 2020

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease

artículo científico publicado en 2020

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

artículo científico publicado en 2008

Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2016

Letter: Invasive nocardiosis, disseminated varicella zoster reactivation and pneumocystis jiroveci pneumoniae associated with tofacitinib and concomitant systemic corticosteroid use in ulcerative colitis

scientific article published on 12 September 2020

Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply

artículo científico publicado en 2013

Letter: dry blood spots for anti-TNF treatment monitoring in IBD

scientific article published on 01 May 2013

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

article

Likelihood ratio for Crohn's disease as a function of anti-Saccharomyces cerevisiae antibody concentration.

artículo científico publicado en 2010

Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX

artículo científico publicado en 2020

Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging

Long-Term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease

artículo científico publicado en 2018

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.

artículo científico publicado en 2016

Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study

scientific article published on 01 October 2019

Long-term Efficacy of Vedolizumab for Crohn's Disease

artículo científico publicado en 2016

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

artículo científico publicado en 2016

Long-term functional outcome after ileal pouch anal anastomosis in 191 patients with ulcerative colitis

artículo científico publicado en 2014

Long-term outcome after infliximab for refractory ulcerative colitis

scholarly article by Marc Ferrante et al published September 2008 in Journal of Crohn's and Colitis

Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy

artículo científico publicado en 2009

Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease

artículo científico publicado en 2019

Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission

artículo científico publicado en 2014

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

artículo científico publicado en 2008

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

artículo científico publicado en 2004

Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort

scientific article published on 06 July 2020

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

artículo científico publicado en 2008

Long-term safety of vedolizumab for inflammatory bowel disease

scientific article published on 02 September 2020

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease

Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC.

artículo científico publicado en 2017

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

artículo científico publicado en 2015

Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study

artículo científico publicado en 2011

Management of acute severe ulcerative colitis

artículo científico publicado en 2010

Management of inflammatory bowel disease in pregnancy

artículo científico publicado en 2012

Management of loss of response to anti-TNF drugs: Change the dose or change the drug?

article

Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.

artículo científico publicado en 2011

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease

artículo científico publicado en 2006

Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn’s disease

article

Mannan-binding lectin gene polymorphisms in ulcerative colitis and Crohn's disease

article

Medical treatment of inflammatory bowel diseases.

artículo científico publicado en 2005

Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.

artículo científico publicado en 2009

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scientific journal article

Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial

artículo científico publicado en 2013

Mo1810 – Faecal Calprotectin Concentration in Inflammatory Bowel Disease and Controls: the Impact of Storage Time and Freeze-Thaw Cycles

scholarly article

Mo1816 – Prediction of Endoscopic Activity in Patients with Crohn’s Disease – Systematic Review and External Validation of Published Prediction Models

scholarly article

Mo1874 – Increased Ncr+ Ilc3 Levels After Biological Therapy in IBD Patients

scholarly article

Mo1897 – Biological Therapies in Chronic Antibiotic-Refractory Pouchitis: A Retrospective Single Centre Experience

scholarly article

Mo1910 – Long-Term Clinical Efficacy of Ustekinumab in Refractory Crohn’s Disease: A Multi-Centre Belgian Cohort Study

scholarly article

Mo1926 – A Single Center Experience: Fecal Microbiota Transplantation As Treatment for Recurrent Clostridium Difficile Infections

scholarly article

Mo2046 – Automated Real Time Endoscopic Scoring Based on Machine Learning in Ulcerative Colitis. Red Density Reliability and Responsiveness Study

scholarly article

Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients with Crohn's Disease

artículo científico publicado en 2020

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis

artículo científico publicado en 2020

Molecular reclassification of Crohn's disease by cluster analysis of genetic variants

artículo científico publicado en 2010

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease

artículo científico publicado en 2019

Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?

artículo científico publicado en 2020

Mucosal Gene Expression Profiling Differentiates Early From Late Ileal Crohn's Disease

artículo científico publicado en 2011

Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-based vs Trough Concentration-based Dosing of Infliximab

artículo científico publicado en 2017

Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease

scientific article published on 20 January 2019

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment

artículo científico publicado en 2009

Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.

artículo científico publicado en 2011

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

artículo científico publicado en 2009

Mucosal healing and anti TNFs in IBD.

artículo científico publicado en 2010

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

artículo científico publicado en 2007

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

artículo científico publicado en 2009

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

artículo científico publicado en 2009

Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation

artículo científico publicado en 2020

Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease

artículo científico publicado en 2018

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis

artículo científico publicado en 2010

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

artículo científico publicado en 2007

NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.

artículo científico publicado en 2017

NOD2/CARD15 disease associations other than Crohn's disease

artículo científico publicado en 2007

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

article

NOD2/CARD15 mutations in Croatian patients with Crohn??s disease: prevalence and genotype???phenotype relationship

artículo científico publicado en 2006

NOD2/CARD15: relevance in clinical practice

artículo científico publicado en 2004

Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis

artículo científico publicado en 2013

Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.

artículo científico publicado en 2014

Neutrophilic HGF-MET signaling exacerbates intestinal inflammation

scientific article published on 17 June 2020

New biologics and small molecules in inflammatory bowel disease: an update.

artículo científico publicado en 2019

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

artículo científico publicado en 2007

New treatment options for inflammatory bowel diseases.

artículo científico publicado en 2018

No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of Rutgeerts' Scoring System

artículo científico publicado en 2018

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease

scientific article published on 01 January 2006

No association between month of birth and Crohn's disease

Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

artículo científico publicado en 2007

Novel Susceptibility Loci for Primary Sclerosing Cholangitis Identified by Genome-Wide Association and Replication Analysis

artículo científico publicado en 2011

Novel Targeted Therapies for Inflammatory Bowel Disease

artículo científico publicado en 2016

Novel biological strategies in inflammatory bowel diseases

artículo científico publicado en 2004

O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohnʼs Disease Refractory to Anti-TFNα

OC-005 A Multicenter, Double-Blind, Placebo (PBO)-Controlled Ph3 Study of Ustekinumab (UST), A Human IL-12/23P40 MAB, in Moderate-Severe Crohn’s Disease (CD) Refractory to anti-TNFΑ: UNITI-1

Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study

artículo científico publicado en 2012

Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)

artículo científico publicado en 2019

Optimising infliximab induction dosing for patients with ulcerative colitis

scientific article published on 10 February 2019

Optimizing anti-TNF treatment in inflammatory bowel disease

artículo científico publicado en 2004

Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).

artículo científico publicado en 2009

Optimizing treatment of inflammatory bowel diseases with biologic agents

scientific article published on December 2008

Oral SMAD7 antisense drug for Crohn's disease.

artículo científico publicado en 2015

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2005

Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis

artículo científico publicado en 2008

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee

artículo científico publicado en 2014

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

article

Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience

scientific article published on 20 August 2019

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

artículo científico publicado en 2011

Outcome of restorative proctocolectomy with ileo-anal pouch for ulcerative colitis: effect of changes in clinical practice

artículo científico publicado en 2017

Outcome of surgery for rectovaginal fistula due to Crohn's disease

scientific article published on 01 October 2009

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial

scientific article published on 08 December 2020

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

artículo científico publicado en 2016

PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis

artículo científico publicado en 2017

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

artículo científico publicado en 2016

Pancreatic Autoantibodies in Inflammatory Bowel Disease

article

Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

artículo científico

Patients with High Anti-drug Antibody Titers Require a Higher Cumulative Infliximab Dose to Achieve Target Drug Concentrations: A Post-hoc Analysis of the TAXIT Trial ⬇️

scholarly article

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

artículo científico publicado en 2018

Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy

artículo científico publicado en 2017

Pharmacogenetics in inflammatory bowel disease

artículo científico publicado en 2006

Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment

artículo científico publicado en 2016

Pharmacokinetics of adalimumab in Crohn's disease

artículo científico publicado en 2015

Phenotype at diagnosis predicts recurrence rates in Crohn's disease

artículo científico publicado en 2005

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

artículo científico publicado en 2018

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.

artículo científico publicado en 2005

Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit*

article

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

artículo científico publicado en 2014

Population-level analysis ofBlastocystissubtype prevalence and variation in the human gut microbiota

artículo científico publicado en 2018

Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis

artículo científico publicado en 2016

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial

artículo científico publicado en 2014

Postinfectious Irritable Bowel Syndrome: A Genetic Link Identified?

Predicting relapse in Crohn's disease: a biopsychosocial model

article

Predicting the response to infliximab from trough serum levels

article

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

artículo científico publicado en 2007

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.

artículo científico publicado en 2010

Predictors of early response to infliximab in patients with ulcerative colitis.

artículo científico publicado en 2007

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

artículo científico publicado en 2019

Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis

artículo científico publicado en 2005

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people

artículo científico publicado en 2007

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines

artículo científico publicado en 2016

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

artículo científico publicado en 2016

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

article

Profile of Belgian Pediatric Crohn Disease (CD) Patients: Presentation and Diagnostic Features

artículo científico publicado en 2011

Profile of Belgian Pediatric Crohn's Disease (CD) Patients: Associations Between Variables at Diagnosis

artículo científico publicado en 2011

Profile of pediatric Crohn's disease in Belgium.

artículo científico publicado en 2013

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

scholarly article by Talat Bessissow et al published November 2012 in The American Journal of Gastroenterology

Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

artículo científico publicado en 2016

Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study

scientific article published on 08 January 2018

Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics

artículo científico publicado en 2013

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

artículo científico publicado en 2005

Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases

scientific article published on 15 October 2019

Protein-losing enteropathy in Crohn's disease

scientific article published on 01 October 2006

Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.

artículo científico publicado en 2015

Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses

artículo científico publicado en 2019

Quantitative microbiome profiling links gut community variation to microbial load.

artículo científico publicado en 2017

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

artículo científico publicado en 2015

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).

artículo científico publicado en 2017

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

artículo científico publicado en 2003

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

scientific article published on 01 September 2019

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation

artículo científico publicado en 2016

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

artículo científico publicado en 2004

Rates of Post-operative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies

artículo científico publicado en 2020

Recent advances: Personalised use of current Crohn's disease therapeutic options

artículo científico

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.

artículo científico publicado en 2010

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report

artículo científico publicado en 2011

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus

artículo científico publicado en 2012

Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis

artículo científico publicado en 2010

Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.

artículo científico publicado en 2011

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease

scientific article published on 29 August 2019

Reply

artículo científico publicado en 2018

Reply to Dr. Caprilli et al.'s letter

Reply to Falvey et al.

artículo científico publicado en 2013

Reply: To PMID 24486408

scientific article published on 21 June 2015

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

scholarly article by Matthieu Allez et al published October 2010 in Journal of Crohn's and Colitis

Republished: Recent advances: personalised use of current Crohn's disease therapeutic options

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

artículo científico publicado en 2011

Response to Letter to the Editor

artículo científico publicado en 2020

Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.

artículo científico publicado en 2015

Restoration of soluble CD146 in patients with Crohnʼs disease treated with the TNF-α antagonist infliximab

article published in 2007

Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.

artículo científico publicado en 2007

Review article: Infliximab therapy for inflammatory bowel disease--seven years on

artículo científico publicado en 2006

Review article: anti-adhesion therapies for inflammatory bowel disease

artículo científico publicado en 2014

Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.

artículo científico publicado en 2006

Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease

scientific article published on 24 September 2020

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy

artículo científico publicado en 2012

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

artículo científico publicado en 2011

Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model

artículo científico publicado en 2017

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia

scientific article published on 13 June 2019

Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse

artículo científico publicado en 2015

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohnʼs disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease

Role of Haptoglobin in Susceptibility of IBD and in Triggering Murine Colitis

artículo científico publicado en 2011

Role of biomarkers in the diagnosis of inflammatory bowel disease

Role of genetics in prediction of disease course and response to therapy

artículo científico publicado en 2010

Sa1697 - Outcome of Pregnancies in Vedolizumab Treated Female IBD Patients

artículo científico publicado en 2018

Sa1752 - Ozanimod Induces Dose-Responsive Histological Improvement with High Agreement with Clinical Remission and Endoscopic Mucosal Healing: Results from the Touchstone Study

artículo científico publicado en 2018

Sa1846 Sequential T2 Relaxometry as a Non-Invasive Assessment of Transmural Inflammation in a Murine Model of Chronically Relapsing Colitis

scientific article published in 2012

Sa1878 – Effects of Subcutaneous Vedolizumab on Health-Related Quality of Life and Work Productivity in Patients with Ulcerative Colitis: Results from the Phase 3 Visible 1 Trial

scholarly article

Safety and Efficacy of Long-Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension ⬇️

scholarly article

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study

artículo científico publicado en 2015

Safety issues with biological therapies for inflammatory bowel disease

artículo científico publicado en 2006

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

artículo científico publicado en 2016

Scoring endoscopic disease activity in IBD: artificial intelligence sees more and better than we do

artículo científico publicado en 2019

Search for evidence of recurring or persistent viruses in Crohn's disease

article

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)

artículo científico publicado en 2015

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

artículo científico publicado en 2012

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

artículo científico

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

artículo científico publicado en 2014

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

artículo científico publicado en 2008

SerologAical diagAnosis of inflammatory bowel disease

artículo científico publicado en 2000

Serologic Markers in the Diagnosis and Management of IBD.

artículo científico publicado en 2007

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

artículo científico publicado en 2007

Seroreactivity against glycolytic enzymes in inflammatory bowel disease

artículo científico publicado en 2011

Seroreactivity to Elongation Factor EF-TS and to TrpR Binding Protein From Klebsiella Pneumoniae in Crohn's Disease and Ulcerative Colitis Patients

artículo científico publicado en 2011

Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease

artículo científico publicado en 2015

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

Serum adalimumab concentration and clinical remission in patients with Crohn's disease

artículo científico publicado en 2013

Serum sickness, encephalitis and other complications of anti-cytokine therapy

artículo científico publicado en 2009

Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease

artículo científico publicado en 2019

Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.

artículo científico publicado en 2015

Should family members of IBD patients be screened for CARD15/NOD2 mutations?

artículo científico publicado en 2008

Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania

artículo científico publicado en 2005

Small Bowel Adenocarcinomas Complicating Crohnʼs Disease Are Associated With Dysplasia

Small bowel review: Diseases of the small intestine

article

Small bowel review: Normal physiology, part 1.

artículo científico publicado en 2003

Small bowel review: Normal physiology, part 2.

artículo científico publicado en 2003

Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.

artículo científico publicado en 2015

Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease

artículo científico publicado en 2015

Su1771 – Systems Genomics of Ulcerative Colitis: Combining Gwas, Signalling and Transcriptional Networks to Uncover Novel Pathogenic Pathways

scholarly article

Su1791 – Longterm Outcome of Pediatric Patients with Inflammatory Bowel Disease Treated with Immunomodulators

scholarly article

Su1794 - Discrimination of Endoscopic Postoperative Recurrence in Patients with Crohn's Disease using Serological Inflammatory Markers

artículo científico publicado en 2018

Su1827 – Organoids Derived from Inflamed and Non Inflamed Intestinal Biopsies of Patients with Ulcerative Colitis Show Comparable Inflammatory Signatures Over Time During Ex Vivo Culture

scholarly article

Su1846 – Outcomes of Pregnancy in IBD Patietns Treated with Vedolizumab, Anti-TNF Or Conventional Therapy

scholarly article

Su1898 – Hepatocyte Growth Factor and Met, Novel Drug Targets Impairing Neutrophil Recruitment in Ulcerative Colitis ?

scholarly article

Su1909 – Predicting Endoscopic Response in Ustekinumab Treated Patients with Crohn’s Disease Trhough an Integrated Multiomics Biomarker

scholarly article

Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study

artículo científico publicado en 2019

Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre Study.

artículo científico publicado en 2016

Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients

artículo científico publicado en 2019

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

article by Gert Van Assche et al published 23 September 2011 in Gut

Systematic Literature Review on the Immunogenicity of Biologics in Inflammatory Bowel Disease ⬇️

artículo científico publicado en 2016

Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease

artículo científico publicado en 2019

Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence

scientific article published on 29 April 2015

T2 Relaxometry Distinguishes Acute Murine DSS Colitis From Chronic Relapsing Colitis. A Novel Tool to Assess Transmural Fibrotic Lesions?

artículo científico publicado en 2011

TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism

artículo científico publicado en 2018

TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?

artículo científico publicado en 2018

Targeting TNF-α for the treatment of inflammatory bowel disease

artículo científico publicado en 2013

Temporal variability in quantitative human gut microbiome profiles and implications for clinical research

artículo científico publicado en 2021

The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction network

artículo científico publicado en 2008

The IL-10R1 S138G loss-of-function allele and ulcerative colitis.

artículo científico publicado en 2008

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

artículo científico publicado en 2010

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients

artículo científico publicado en 2015

The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews

artículo científico publicado en 2016

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile

artículo científico publicado en 2015

The Protease Genes Cyld and USP40 Are Associated With Crohn's Disease: Results From a European Consortium

artículo científico publicado en 2011

The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis

artículo científico publicado en 2007

The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?

scientific article published on 19 May 2020

The Role of FC Gamma Receptor (FCGR) Mutations in the Response to Infliximab in Inflammatory Bowel Disease

artículo científico publicado en 2011

The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohnʼs disease

article

The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor

scientific article published on 01 February 2020

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

scientific article published on 01 May 2006

The changing face of treatment for Crohn's disease

artículo científico publicado en 2006

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohnâ s disease after failure of two other anti-TNF antibodies

artículo científico publicado en 2010

The genetic architecture of inflammatory bowel disease: past, present and future

artículo científico publicado en 2015

The human microbiome in health and disease: hype or hope

article

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

artículo científico publicado en 2005

The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients

artículo científico publicado en 2005

The intestinal barrier: a fundamental role in health and disease

artículo científico publicado en 2017

The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases

artículo científico publicado en 2016

The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study

artículo científico publicado en 2011

The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease

artículo científico publicado en 2018

The potential for disease modification in Crohn's disease

artículo científico publicado en 2010

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients

article

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

artículo científico publicado en 2014

The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study

artículo científico publicado en 2004

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

artículo científico publicado en 2005

The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease

artículo científico publicado en 2013

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

artículo científico

The role of genetics in inflammatory bowel disease

artículo científico publicado en 2008

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

article

The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.

artículo científico publicado en 2006

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

artículo científico publicado en 2009

The value of serologic markers in indeterminate colitis: a prospective follow-up study

artículo científico publicado en 2002

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives

artículo científico

Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease

artículo científico publicado en 2017

Therapeutic innovations in inflammatory bowel diseases

artículo científico publicado en 2015

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

article by Geert R. D'Haens et al published October 2008 in Gastroenterology

Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease

artículo científico publicado en 2020

Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place

artículo científico publicado en 2020

Three Genetic Susceptibility Loci Indicate a Role for IL2, REL and CARD9 in Primary Sclerosing Cholangitis

artículo científico publicado en 2011

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

artículo científico publicado en 2011

Thromboembolism as an important complication of inflammatory bowel disease

artículo científico publicado en 2016

Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations

artículo científico publicado en 2020

To what extent are genetics clinically useful?

artículo científico publicado en 2011

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2017

Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments ⬇️

artículo científico publicado en 2016

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

artículo científico publicado en 2017

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

artículo científico publicado en 2019

Tolerability of Shortened Infliximab Infusion Times in Patients With Inflammatory Bowel Diseases: A Single-Center Cohort Study

artículo científico publicado en 2011

Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease

scientific article published on 06 December 2006

Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.

artículo científico publicado en 2006

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

artículo científico publicado en 2005

Towards a novel molecular classification of IBD.

artículo científico publicado en 2012

Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.

artículo científico publicado en 2008

Transmission Ratio Distortion of DLG5 R30Q: Evidence for Prenatal Selection?

article

Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease

artículo científico publicado en 2004

Treat to Target in Inflammatory Bowel Disease.

artículo científico publicado en 2016

Treatment inferred disease severity in Crohn's disease: Evidence for a European gradient of disease course

article

Treatment of severe steroid refractory ulcerative colitis

scientific article published on September 2008

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease

artículo científico publicado en 2015

Tu1713 – Efficacy and Safety of 2 Or 3 Vedolizumab Intravenous Infusions As Induction Therapy for Ulcerative Colitis and Crohn's Disease: Results from Visible 1 and 2

scholarly article

Tu1727 – Rapidity of Symptomatic and Inflammatory Biomarker Improvements Following Upadacitinib Induction Treatment: Data from the U-Achieve Study

scholarly article

Tu1733 – Clinical Remission Demonstrated with Oral Ozanimod in the Overall Population and Across Multiple Subgroups of Patients with Moderately to Severely Active Ulcerative Colitis in the Touchstone Trial

scholarly article

Tu1737 – Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Ulcerative Colitis: Results from the Open-Label Extension Study Turandot Ii

scholarly article

Tu1738 – Biomarker and Pharmacokinetic Data from the Turandot Ii Open-Label Extension Study of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Patients with Ulcerative Colitis

scholarly article

Tu1745 – Correlation of Fecal Calprotectin and C-Reactive Protein Concentrations with Clinical Outcomes and Endoscopic Disease Activity in Patients with Ulcerative Colitis Receiving Induction Therapy with Etrasimod

scholarly article

Tu1768 – Identifying Molecular Features Contributing to Disease Heterogeneity in Crohn's Disease Using Multi-Omic Data Integration

scholarly article

Tu1789 – Treatment Response to Ustekinumab and Vedolizumab in Inflammatory Bowel Disease: the Predictive Role of Gut Microbiota

scholarly article

Tu1799 - Serum Proteomic Profiling Reveals Changes in Inflammatory Profiles with Consecutive Biological Therapies in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

Tu1810 - Transcriptomic Profile of Inflamed Colonic Biopsies from Newly Diagnosed Crohn's Disease and Ulcerative Colitis Patients Depend on the age at Diagnosis

artículo científico publicado en 2018

Tu1819 – Serum Marker Panel for Detection of Mucosal Healing in Vedolizumab Treated Patients with Ulcerative Colitis

scholarly article

Tu1821 – Pharmacokinetic and Pharmacodynamic Evaluation of Radiological Healing in Crohn's Disease Patients Treated with Infliximab: A Tailorix Mre Substudy

scholarly article

Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening

artículo científico publicado en 2013

Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes

artículo científico publicado en 2005

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

article

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis

artículo científico publicado en 2020

Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease

artículo científico publicado en 2013

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

scientific article published on 06 February 2019

Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network

artículo científico publicado en 2015

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer

artículo científico publicado en 2016

Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates

scientific article published on 01 July 2019

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

artículo científico publicado en 2016

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

artículo científico publicado en 2003

Vaccination and infection prevention in inflammatory bowel disease

artículo científico publicado en 2010

Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.

artículo científico publicado en 2006

Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay

artículo científico publicado en 2016

Value of drug level testing and antibody assays in optimising biological therapy

artículo científico publicado en 2012

Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis

artículo científico publicado en 2016

Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis

scientific article published on 14 October 2020

Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.

artículo científico publicado en 2011

Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn's Disease or Ulcerative Colitis

artículo científico publicado en 2020

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease

artículo científico publicado en 2019

Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.

artículo científico publicado en 2017

Vedolizumab in refractory microscopic colitis: an international case series

scientific article published on 01 March 2019

Vedolizumab treatment persistence and safety in a 2-year data analysis of an extended access programme

artículo científico publicado en 2020

Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview

What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?

artículo científico publicado en 2008

What is the role of endoscopy in predicting Crohn's disease relapse or course?

scientific article published on 01 October 2008

When IBD is not IBD

scientific article published on 26 September 2018

Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease

artículo científico publicado en 2015

Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.

artículo científico publicado en 2014

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

artículo científico publicado en 2008

Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating form

artículo científico publicado en 2020

Influencia de la inmunogenicidad en la eficacia a largo plazo del infliximab en la enfermedad de Crohn

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda